Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Clinical trial NCT06506643 · RECRUITING
Trial details
- NCT number
- NCT06506643
- Sponsor
- Vector Vitale LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2028-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.